Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Bloomin' Brands director Lal Rohit bought 10,000 common shares on March 11, 2026, at $5.69 per share, bringing his direct holdings to 30,156.085 shares. The purchase occurred while the stock traded close to its 52-week low and shortly after the company reported mixed fiscal 2025 fourth-quarter results, including an EPS beat and a revenue shortfall.
Alight, Inc. Chief Executive Officer Verma Rohit purchased 112,000 shares of the company’s Class A Common Stock on March 12, 2026, spending $99,680 at $0.89 per share, according to a Form 4 filing with the Securities and Exchange Commission. The transaction increases Rohit’s direct holdings to 1,134,883 shares and comes while the shares trade near …
Klaviyo co-CEO Andrew Bialecki sold 206,827 shares of Series A common stock on March 10, 2026, for roughly $4.1 million and simultaneously converted the same number of Series A shares into Series B, according to an SEC Form 4. The stock trades below the sale range, while the company unveiled a $500 million buyback program and a strategic AI partner…
Palladyne AI Corp. Chief Financial Officer Trevor Thatcher sold 7,649 shares on March 12, 2026, at $7.55 per share, yielding $57,749 in proceeds. Two days earlier he received 25,000 restricted stock units at no cost under the 2021 Equity Incentive Plan. The stock has fallen to $7.06 and InvestingPro analysis flags the name as overvalued with high p…
Palladyne AI Corp's Chief Legal Officer, Stephen Sonne, sold 6,802 shares on March 12, 2026, for $51,355 at $7.55 per share. Two days earlier he was granted 25,000 restricted stock units that carry a reported $0 value and $0 per-share price. After these moves Sonne directly holds 206,206 shares. The company posted a 118% year-over-year revenue incr…
Palladyne AI Corp.'s chief technology officer, Denis Garagic, sold 12,945 shares on March 12, 2026, for $97,734. The transaction occurred amid pronounced price swings for PDYN, which has gained 66% year-to-date but fell 17% in the prior week. Earlier on March 10 Garagic received 35,000 restricted stock units. Separately, the company reported a 118%…
Patrick Industries director M. Scott Welch acquired 10,000 shares of common stock in transactions that totaled roughly $1.13 million. The purchase comes amid a recent analyst re-rating following better-than-expected fourth-quarter 2025 results and alongside InvestingPro commentary on the stock's valuation.
Director Sachin Chand Jaitly sold Class A common stock of Figure Technology Solutions on March 10, 2026, in transactions totaling $7.29 million. The dispositions involved multiple lots at weighted average prices between $33.5012 and $34.3848 and left the Tessera Venture Capital funds with no remaining holdings. The moves come amid mixed company fun…
Bradley C Allen Jr., a director at Stewart Information Services Corp (NYSE:STC), bought 1,000 shares across transactions on March 11 and March 12, 2026, totaling $62,757. The purchases took place while the stock quoted $63.27, beneath an InvestingPro Fair Value estimate of $68.70. Recent company results included an EPS miss for Q4 2025 but revenue …
Reliance Global Group NASDAQ:EZRA Chief Financial Officer Joel Markovits reported several insider sales in filings with the SEC. The transactions, executed in September and November 2025, total 79,243 shares sold for roughly $79,243 at prices between $0.66 and $0.88. Additional disposals were recorded to satisfy tax obligations. The trades occur wh…
Sinclair, Inc. Executive Chairman David D. Smith bought 97,285 shares of Class A Common Stock on March 28, 2025, in a transaction valued at roughly $1.5 million. The purchase occurred as the stock traded below the acquisition price and followed company results that beat guidance on adjusted EBITDA. Sinclair offers a 7.22% dividend yield and recentl…
Craig F. Courtemanche Jr., a director at Procore Technologies, sold roughly $3.2 million of company stock on March 10, 2026, under a pre-set 10b5-1 trading plan while simultaneously exercising options to acquire the same number of shares. The moves follow a quarter in which Procore reported results above expectations and announced several senior ex…
Kevin J O’Connor, a director on Procore Technologies' board, sold 15,384 shares of the company's common stock across transactions on March 10 and March 11, 2026, realizing roughly $882,480. The trades were executed under a pre-established 10b5-1 trading plan. Procore recently reported Q4 2025 earnings and revenue that slightly beat estimates and an…
Interim principal financial officer and principal accounting officer Sitaram Siddharth sold 2,319 shares of Doximity Class A common stock on March 10, 2026, through an automatic Rule 10b5-1 plan for proceeds of $58,833. On the same day he converted 5,000 Class B shares into Class A shares and exercised 5,000 options at a $4.12 strike. Doximity’s sh…
Interim Principal Financial Officer and Principal Accounting Officer Sitaram Siddharth sold a block of Doximity Class A shares on February 10, 2026 through an automated Rule 10b5-1 plan, while also converting Class B shares to Class A and exercising employee stock options. The transactions coincide with a material share price decline over the prior…
Richard M. Cashin Jr., a 10% owner of AdaptHealth Corp (NASDAQ:AHCO), acquired 2,046,691 shares between March 10 and March 12, 2026, for roughly $19.9 million. The purchases were executed in multiple transactions at prices between $9.7281 and $9.7299 per share. The stock has been flagged by InvestingPro analysis as potentially undervalued, noting a…
Charles Dirkson R, President, Chief Executive Officer and Executive Co-Chairman of Loar Holdings Inc (NASDAQ:LOAR), acquired company common stock through Charles Family Trust 13 in three purchases between March 10 and March 12, 2026, totaling $2967830. The transactions increased the trust's position to 4,087,005 shares as Loar reported strong fourt…
Baskett Forest, a roughly 10% holder of Korro Bio, bought 207,100 common shares and 242,945 pre-funded warrants on March 10, 2026, at prices of $11.11 and $11.109 respectively, for a combined common-stock purchase of $2,300,881. The move leaves the investor with an indirect holding of 1,297,893 Korro Bio shares as the company approaches its March 1…
Antero Midstream director Brooks J. Klimley sold 5,000 shares on March 12, 2026, realizing $115,800 at $23.16 per share. The sale occurred while the stock traded close to its 52-week high and after sizable recent gains. The company also reported Q4 2025 results that beat EPS estimates but missed revenue expectations, and closed a $400 million sale …
Edward T. Mathers, a 10% holder of Korro Bio, acquired 207,100 shares of the company's common stock and 242,945 pre-funded warrants on March 10, 2026, spending roughly $2.3 million on the common shares. The transaction precedes a scheduled earnings report and follows an $85 million private investment in public equity financing and a series of analy…
Mohamad Makhzoumi, who holds a roughly 10% stake in Korro Bio, bought 207,100 shares at $11.11 each on March 10, 2026, a transaction valued at $2,300,881. The purchase was filed on a Form 4 with the SEC. Makhzoumi also acquired 242,945 Pre-Funded Warrants at $11.109 and now indirectly owns 1,297,893 Korro Bio shares. The company has announced a pri…
Sera Prognostics Chief Information Officer Harrison Robert Gardner sold 716 Class A shares on March 11, 2026, for $2.04 each, netting $1,460 to meet tax obligations tied to vested restricted stock units. The transaction was executed as a block trade across prices of $1.90 to $2.30. The stock trades near $1.99 and has fallen 51% over the past year. …
Benjamin Jackson, general counsel of Sera Prognostics, sold 1,027 shares of the company's Class A common stock on March 11, 2026, in a transaction that generated roughly $2,095. The sale, disclosed on a Form 4 filing, was described as a means to satisfy tax withholding tied to the vesting of restricted stock units. The move comes amid positive clin…
Sera Prognostics Chief Scientific Officer John J. Boniface sold 1,517 shares of Class A common stock on March 11, 2026, to satisfy tax withholding related to vested restricted stock units. The trade amounted to roughly $3,094 at a weighted average price of $2.04. The company has recently reported strong clinical-trial data for its PreTRM test and r…
Rapid Micro Biosystems Chief Financial Officer Sean M. Wirtjes sold 7,480 shares on March 11, 2026, at $4.3181 per share to satisfy tax obligations tied to vested restricted stock units. The disposition totaled roughly $32,299 and leaves Wirtjes with 556,194 shares. The stock is trading below the sale price amid recent short-term weakness, and the …
